During this course experts will present information on melanoma prevention, risk assessment, early detection, genetic factors, and emerging treatment options.
San Diego Mission Bay Resort
1775 E Mission Bay Drive
San Diego, California 92109
As the incidence of melanoma continues to rise rapidly in the United States and around the world, the need to educate clinicians from various specialties on the disease also increases. During this course nationally recognized experts will present information on prevention, risk assessment, early detection, genetic factors, and current and future treatment choices for melanoma patients. Issues concerning surgical management, adjuvant therapy, advanced disease therapy, and personalizing the course of treatment for individual patients will also be discussed. This course is designed to provide information that will help clinicians in their decision making regarding these difficult patient problems. The course will be taught by a wide range of experts as this most serious of skin cancers will require multidisciplinary efforts to conquer.
After attending this live activity, participants should be able to:
- Demonstrate how newly discovered, evidence-based scientific information applies to the current practice of clinical dermatology.
- Describe the epidemiology and risk factors associated with the increasing incidence of cutaneous melanoma.
- Examine current data and new strategies for the prevention of melanoma.
- Relate case studies to other healthcare professionals to improve patient care.
- Evaluate and diagnose a variety of malignancies related to melanoma skin cancer.
- Identify possible genetic mutations and etiologic factors in the melanoma patient and diagnose patients based on dermatologic manifestations.
- Incorporate new diagnostic techniques, including dermoscopy, into practice.
- Determine appropriate treatment for patients with metastatic melanoma, melanonychia and ocular melanoma.
- Integrate new therapies and treatments for advanced melanoma including surgical techniques.
- Discuss the effectiveness of neoadjuvant therapy and immunotherapy in treating melanoma.
- Navigate the medico-legal aspects of caring for the melanoma patient.
- Recommend strategies for managing patients with multiple melanomas.
- Provide optimal follow-up of patients after melanoma treatment.
Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Nurses and Nurse Practitioners
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.
For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit(s)™ for attendance at structured learning activities offered by organizations accredited by the ACCME.
The American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
NCCPA accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
This course is supported, in part, by educational grants from industry. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, a complete list of commercial support received will be provided to all learners who participate in the continuing education activity. For more information: www.accme.org/standards
Cultural & Linguistic Competency and Implicit Bias
This activity is designed to include curriculum addressing the topics of cultural and linguistic competency (CLC) and implicit bias (IB) in compliance with California Business and Professions (B&P) Code Section 2190. All those involved in the planning and execution of this activity have been asked to identify and discuss issues relevant to the topics being covered. In addition, a variety of resources are available that address cultural and linguistic competency and implicit bias. A resource document can be downloaded from the Conference Details section above.
Date and time
Sun, Jan 23, 2022 at 12 pm